Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
129.17B
Market cap129.17B
Price-Earnings ratio
26.91
Price-Earnings ratio26.91
Dividend yield
2.83%
Dividend yield2.83%
Average volume
5.38M
Average volume5.38M
High today
$101.07
High today$101.07
Low today
$99.49
Low today$99.49
Open price
$99.63
Open price$99.63
Volume
5.93M
Volume5.93M
52 Week high
$106.33
52 Week high$106.33
52 Week low
$79.29
52 Week low$79.29

Stock Snapshot

As of today, Medtronic(MDT) shares are valued at $100.59. The company's market cap stands at 129.17B, with a P/E ratio of 26.91 and a dividend yield of 2.8%.

On 2025-12-10, Medtronic(MDT) stock moved within a range of $99.49 to $101.07. With shares now at $100.59, the stock is trading +1.1% above its intraday low and -0.5% below the session's peak.

Trading volume for Medtronic(MDT) stock has reached 5.93M, versus its average volume of 5.38M.

Over the past 52 weeks, Medtronic(MDT) stock has traded between a high of $106.33 and a low of $79.29.

Over the past 52 weeks, Medtronic(MDT) stock has traded between a high of $106.33 and a low of $79.29.

MDT News

Simply Wall St 21h
Has Medtronic’s Recent 24% Rally Left Enough Upside After Robotics and Diabetes Push?

If you are wondering whether Medtronic remains a solid value play after its recent run, or if the easy money has already been made, you are in the right place....

Has Medtronic’s Recent 24% Rally Left Enough Upside After Robotics and Diabetes Push?
TipRanks 3d
Medtronic upgraded to Buy from Hold at Nephron Research

Nephron Research upgraded Medtronic (MDT) to Buy from Hold with a $120 price target The firm says the company’s pickup in growth “has legs.” TipRanks Cyber Mon...

Nasdaq 3d
Forget Medtronic, Buy This Healthcare Stock Instead

Key Points Medtronic is a solid choice for dividend investors, but Intuitive Surgical is a better option for growth-oriented investors. Intuitive Surgical wil...

Forget Medtronic, Buy This Healthcare Stock Instead

Analyst ratings

53%

of 32 ratings
Buy
53.1%
Hold
46.9%
Sell
0%

More MDT News

Benzinga 7d
Medtronic Scores FDA Win As Hugo Surgical Robot Enters 230,000 Urology Procedure Market

On Wednesday, the U.S. Food and Drug Administration (FDA) cleared Medtronic Plc’s (NYSE:MDT) Hugo robotic-assisted surgery (RAS) system for use in urologic surg...

Nasdaq 7d
FDA Clears Medtronic's Hugo Robotic-Assisted Surgery System For Urologic Procedures

(RTTNews) - Medtronic (MDT) announced that it has received FDA clearance for its Hugo robotic-assisted surgery (RAS) system in urologic procedures, marking a si...

FDA Clears Medtronic's Hugo Robotic-Assisted Surgery System For Urologic Procedures

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.